Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

Appleman LJ, Beumer JH, Jiang Y, Lin Y, Ding F, Puhalla S, Swartz L, Owonikoko TK, Donald Harvey R, Stoller R, Petro DP, Tawbi HA, Argiris A, Strychor S, Pouquet M, Kiesel B, Chen AP, Gandara D, Belani CP, Chu E, Ramalingam SS.

Cancer Chemother Pharmacol. 2019 Dec;84(6):1289-1301. doi: 10.1007/s00280-019-03960-w. Epub 2019 Sep 23.

PMID:
31549216
2.

Improving atomic displacement and replacement calculations with physically realistic damage models.

Nordlund K, Zinkle SJ, Sand AE, Granberg F, Averback RS, Stoller R, Suzudo T, Malerba L, Banhart F, Weber WJ, Willaime F, Dudarev SL, Simeone D.

Nat Commun. 2018 Mar 14;9(1):1084. doi: 10.1038/s41467-018-03415-5.

3.

Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma.

Quan K, Sutera P, Xu K, Bernard ME, Burton SA, Wegner RE, Zeh H, Bahary N, Stoller R, Heron DE.

Pract Radiat Oncol. 2018 Mar - Apr;8(2):95-106. doi: 10.1016/j.prro.2017.10.001. Epub 2017 Oct 7.

PMID:
29291966
4.

Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland.

Berkovitch M, Ashkenazi-Hoffnung L, Youngster I, Shaniv D, Dil-Nahlieli D, Gorelik E, Schäublin M, Stoller R, Karra N, Schwartzberg E.

Front Pharmacol. 2017 Nov 21;8:843. doi: 10.3389/fphar.2017.00843. eCollection 2017.

5.

Phase I study of veliparib in combination with gemcitabine.

Stoller R, Schmitz JC, Ding F, Puhalla S, Belani CP, Appleman L, Lin Y, Jiang Y, Almokadem S, Petro D, Holleran J, Kiesel BF, Ken Czambel R, Carneiro BA, Kontopodis E, Hershberger PA, Rachid M, Chen A, Chu E, Beumer JH.

Cancer Chemother Pharmacol. 2017 Sep;80(3):631-643. doi: 10.1007/s00280-017-3409-3. Epub 2017 Aug 2.

6.

Impact of Short-Range Forces on Defect Production from High-Energy Collisions.

Stoller RE, Tamm A, Béland LK, Samolyuk GD, Stocks GM, Caro A, Slipchenko LV, Osetsky YN, Aabloo A, Klintenberg M, Wang Y.

J Chem Theory Comput. 2016 Jun 14;12(6):2871-9. doi: 10.1021/acs.jctc.5b01194. Epub 2016 May 23.

PMID:
27110927
7.

Electron-phonon coupling in Ni-based binary alloys with application to displacement cascade modeling.

Samolyuk GD, Béland LK, Stocks GM, Stoller RE.

J Phys Condens Matter. 2016 May 5;28(17):175501. doi: 10.1088/0953-8984/28/17/175501. Epub 2016 Apr 1.

PMID:
27033732
8.

Direct Observation of Defect Range and Evolution in Ion-Irradiated Single Crystalline Ni and Ni Binary Alloys.

Lu C, Jin K, Béland LK, Zhang F, Yang T, Qiao L, Zhang Y, Bei H, Christen HM, Stoller RE, Wang L.

Sci Rep. 2016 Feb 1;6:19994. doi: 10.1038/srep19994.

9.

Influence of chemical disorder on energy dissipation and defect evolution in concentrated solid solution alloys.

Zhang Y, Stocks GM, Jin K, Lu C, Bei H, Sales BC, Wang L, Béland LK, Stoller RE, Samolyuk GD, Caro M, Caro A, Weber WJ.

Nat Commun. 2015 Oct 28;6:8736. doi: 10.1038/ncomms9736.

10.

Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.

Shah MA, Janjigian YY, Stoller R, Shibata S, Kemeny M, Krishnamurthi S, Su YB, Ocean A, Capanu M, Mehrotra B, Ritch P, Henderson C, Kelsen DP.

J Clin Oncol. 2015 Nov 20;33(33):3874-9.

PMID:
26438119
11.

Recombination radius of a Frenkel pair and capture radius of a self-interstitial atom by vacancy clusters in bcc Fe.

Nakashima K, Stoller RE, Xu H.

J Phys Condens Matter. 2015 Aug 26;27(33):335401. doi: 10.1088/0953-8984/27/33/335401. Epub 2015 Aug 4.

PMID:
26241190
12.

Cascade morphology transition in bcc metals.

Setyawan W, Selby AP, Juslin N, Stoller RE, Wirth BD, Kurtz RJ.

J Phys Condens Matter. 2015 Jun 10;27(22):225402. doi: 10.1088/0953-8984/27/22/225402. Epub 2015 May 18.

PMID:
25985256
13.

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.

Rodon J, Tawbi HA, Thomas AL, Stoller RG, Turtschi CP, Baselga J, Sarantopoulos J, Mahalingam D, Shou Y, Moles MA, Yang L, Granvil C, Hurh E, Rose KL, Amakye DD, Dummer R, Mita AC.

Clin Cancer Res. 2014 Apr 1;20(7):1900-9. doi: 10.1158/1078-0432.CCR-13-1710. Epub 2014 Feb 12.

14.

Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers.

Tawbi H, Christner SM, Lin Y, Johnson M, Mowrey ET, Cherrin C, Chu E, Lee JJ, Puhalla S, Stoller R, Appleman LR, Miller BM, Beumer JH.

Cancer Chemother Pharmacol. 2014 Jan;73(1):207-11. doi: 10.1007/s00280-013-2337-0. Epub 2013 Oct 30.

15.

Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers.

Tawbi HA, Tran AL, Christner SM, Lin Y, Johnson M, Mowrey E, Appleman LR, Stoller R, Miller BM, Egorin MJ, Beumer JH.

Cancer Chemother Pharmacol. 2013 Nov;72(5):1143-7. doi: 10.1007/s00280-013-2283-x. Epub 2013 Sep 14.

16.

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer.

Boone BA, Steve J, Krasinskas AM, Zureikat AH, Lembersky BC, Gibson MK, Stoller RG, Zeh HJ, Bahary N.

J Surg Oncol. 2013 Sep;108(4):236-41. doi: 10.1002/jso.23392.

17.

Solving the puzzle of <100> interstitial loop formation in bcc Iron.

Xu H, Stoller RE, Osetsky YN, Terentyev D.

Phys Rev Lett. 2013 Jun 28;110(26):265503. Epub 2013 Jun 26.

PMID:
23848895
18.

The influence of transition metal solutes on the dislocation core structure and values of the Peierls stress and barrier in tungsten.

Samolyuk GD, Osetsky YN, Stoller RE.

J Phys Condens Matter. 2013 Jan 16;25(2):025403. doi: 10.1088/0953-8984/25/2/025403. Epub 2012 Nov 29.

PMID:
23197153
19.

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.

Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC.

Int J Nanomedicine. 2012;7:5555-64. doi: 10.2147/IJN.S35751. Epub 2012 Oct 19.

20.

Self-evolving atomistic kinetic Monte Carlo: fundamentals and applications.

Xu H, Osetsky YN, Stoller RE.

J Phys Condens Matter. 2012 Sep 19;24(37):375402. doi: 10.1088/0953-8984/24/37/375402. Epub 2012 Aug 23.

PMID:
22914096
21.

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

Chao J, Synold TW, Morgan RJ Jr, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, Ramalingam SS, Davies A, Espinoza-Delgado I, Newman EM, Yen Y.

Cancer Chemother Pharmacol. 2012 Mar;69(3):835-43. doi: 10.1007/s00280-011-1779-5. Epub 2011 Nov 22.

22.

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.

Argiris A, Feinstein TM, Wang L, Yang T, Agrawal S, Appleman LJ, Stoller RG, Grandis JR, Egloff AM.

Invest New Drugs. 2012 Aug;30(4):1575-84. doi: 10.1007/s10637-011-9732-3. Epub 2011 Sep 1.

23.

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.

Carneiro BA, Ramanathan RK, Fakih MG, Krishnamurthi SS, Lembersky BC, Stoller RG, Lancaster SL, Pinkerton RA, Crandall TL, Schmotzer AR, Potter DM, Bahary N.

Clin Colorectal Cancer. 2012 Mar;11(1):53-9. doi: 10.1016/j.clcc.2011.05.003. Epub 2011 Aug 2.

PMID:
21813336
24.

Emergency surgical salvage for severe intracranial aneurysm rupture during endovascular coiling procedures not amenable to additional coiling.

Nussbaum ES, Defillo A, Janjua TM, Zelensky A, Tatman P, Stoller R, Lowary J, Nussbaum LA.

Surg Neurol Int. 2011;2:87. doi: 10.4103/2152-7806.82329. Epub 2011 Jun 30.

25.

Dissecting peripheral superior cerebellar artery aneurysms: Report of two cases and review of the literature.

Nussbaum ES, Defillo A, Zelensky A, Stoller R, Nussbaum L.

Surg Neurol Int. 2011;2:69. doi: 10.4103/2152-7806.81731. Epub 2011 May 28.

26.

Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.

Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC.

J Clin Pharmacol. 2012 Feb;52(2):180-94. doi: 10.1177/0091270010394851.

PMID:
21233302
27.

The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology.

Kastenbaum HA, Khalbuss WE, Felgar RE, Stoller R, Monaco SE.

Cytojournal. 2010 Oct 11;7:20. doi: 10.4103/1742-6413.70966.

28.

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors.

Zamboni WC, Maruca LJ, Strychor S, Zamboni BA, Ramalingam S, Edwards RP, Kim J, Bang Y, Lee H, Friedland DM, Stoller RG, Belani CP, Ramanathan RK.

J Liposome Res. 2011 Jun;21(2):158-65. doi: 10.3109/08982104.2010.496085. Epub 2010 Jul 14.

PMID:
20626314
29.

Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.

Zamboni WC, Strychor S, Maruca L, Ramalingam S, Zamboni BA, Wu H, Friedland DM, Edwards RP, Stoller RG, Belani CP, Ramanathan RK.

Clin Pharmacol Ther. 2009 Nov;86(5):519-26. doi: 10.1038/clpt.2009.141. Epub 2009 Aug 12.

PMID:
19675541
30.

Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.

Zamboni WC, Ramalingam S, Friedland DM, Edwards RP, Stoller RG, Strychor S, Maruca L, Zamboni BA, Belani CP, Ramanathan RK.

Clin Cancer Res. 2009 Feb 15;15(4):1466-72. doi: 10.1158/1078-0432.CCR-08-1405. Epub 2009 Feb 3. Erratum in: Clin Cancer Res. 2009 Apr 15;15(8):2949-50.

31.

Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.

Crawford J, Glaspy JA, Stoller RG, Tomita DK, Vincent ME, McGuire BW, Ozer H.

Support Cancer Ther. 2005 Oct 1;3(1):36-46. doi: 10.3816/SCT.2005.n.023.

PMID:
18632435
32.

A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.

Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP.

Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088.

33.

Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies.

Ramalingam SS, Parise RA, Ramanathan RK, Lagattuta TF, Musguire LA, Stoller RG, Potter DM, Argiris AE, Zwiebel JA, Egorin MJ, Belani CP.

Clin Cancer Res. 2007 Jun 15;13(12):3605-10. Epub 2007 May 17. Erratum in: Clin Cancer Res. 2007 Oct 15;13(20):6245. Ramananthan, Ramesh K [corrected to Ramanathan, Ramesh K].

34.

Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.

Ramanathan RK, Egorin MJ, Eiseman JL, Ramalingam S, Friedland D, Agarwala SS, Ivy SP, Potter DM, Chatta G, Zuhowski EG, Stoller RG, Naret C, Guo J, Belani CP.

Clin Cancer Res. 2007 Mar 15;13(6):1769-74.

35.

Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers.

Janjic B, Andrade P, Wang XF, Fourcade J, Almunia C, Kudela P, Brufsky A, Jacobs S, Friedland D, Stoller R, Gillet D, Herberman RB, Kirkwood JM, Maillere B, Zarour HM.

J Immunol. 2006 Aug 15;177(4):2717-27.

36.

Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy.

Patel H, Stoller R, Auber M, Potter D, Cai C, Zamboni W, Kiefer G, Matin K, Schmotzer A, Ramanathan RK.

Invest New Drugs. 2006 Jul;24(4):359-63.

PMID:
16525767
37.

Magnetic interactions influence the properties of helium defects in iron.

Seletskaia T, Osetsky Y, Stoller RE, Stocks GM.

Phys Rev Lett. 2005 Feb 4;94(4):046403. Epub 2005 Feb 3.

PMID:
15783579
38.

Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.

Abriel H, Schläpfer J, Keller DI, Gavillet B, Buclin T, Biollaz J, Stoller R, Kappenberger L.

Swiss Med Wkly. 2004 Nov 27;134(47-48):685-94. Review.

39.

QT interval prolongation in patients on methadone with concomitant drugs.

Piguet V, Desmeules J, Ehret G, Stoller R, Dayer P.

J Clin Psychopharmacol. 2004 Aug;24(4):446-8. Review. No abstract available.

PMID:
15232338
40.

Omeprazole-induced hepatotoxicity? A case report.

Christe C, Stoller R, Vogt N.

Pharmacoepidemiol Drug Saf. 1998 Aug;7 Suppl 1:S41-4.

PMID:
15073958
41.

Minocycline-induced pericardial effusion.

Christe C, Ricou F, Stoller R, Vogt N.

Ann Pharmacother. 2000 Jul-Aug;34(7-8):875-7.

PMID:
10928400
42.

Omeprazole-induced agranulocytosis in a kidney transplant recipient.

Gabutti L, Stoller R, Vogt B.

Nephrol Dial Transplant. 1999 Feb;14(2):523-4. No abstract available.

PMID:
10069239
43.

[Fluoroquinolones as etiology of tendinopathy].

Gabutti L, Stoller R, Marti HP.

Ther Umsch. 1998 Sep;55(9):558-61. German.

PMID:
9789471
44.

"Buffalo hump" in HIV-1 infection.

Stocker DN, Meier PJ, Stoller R, Fattinger KE.

Lancet. 1998 Jul 25;352(9124):320-1. No abstract available.

PMID:
9690434
45.

Fluoroquinolones as a cause of tendon disorders in patients with renal failure/renal transplants.

Marti HP, Stoller R, Frey FJ.

Br J Rheumatol. 1998 Mar;37(3):343-4. Review. No abstract available.

PMID:
9566681
46.

[Retrospective study of drug-induced agranulocytosis in hospitalized patients in Geneva and comparison with cases reported to IOCM].

Krayenbühl JC, Oestreicher MK, Sievering J, Stoller R, Dayer P.

Schweiz Med Wochenschr. 1998 Feb 7;128(6):199-202. French.

PMID:
9540141
47.

[Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring)].

Ciorciaro C, Hartmann K, Stoller R, Kuhn M.

Schweiz Med Wochenschr. 1996 Dec 7;126(49):2109-13. German.

PMID:
8999497
48.

Adverse drug event reporting at Veterans Affairs facilities.

Corr K, Stoller R, Sloan HS, Babb J, Cason D, Keith MR, Myers CE.

Am J Health Syst Pharm. 1996 Feb 1;53(3):314-5. No abstract available.

PMID:
8808031
49.

Notes on Foucault.

Stoller RJ.

Psychoanal Rev. 1996 Feb;83(1):12-20; discussion 11-2. No abstract available.

PMID:
8713830

Supplemental Content

Loading ...
Support Center